In Brief
This article was originally published in The Tan Sheet
Executive Summary
Plan B One-Step gets generic competition; legislation to restrict DXM introduced again; J&J agrees to reforms in settlement; China recants on MJN formula concerns; Buster line drives Hi-Tech Pharmacal OTC growth; Sabinsa awarded profits from infringed ForsLean trademark; more news In Brief.
You may also be interested in...
In Brief
Perrigo ships generic Mucinex extended-release; Valeant buys Obagi Medical Products; FDA advisory committee will discuss AERs; DXM legislation offered again; bill revived to allow Primatene Mist sales; Intercore will market MeliaLife products; more news In Brief.
Judge Dismisses Complaint Against McNeil Related To Recalled OTCs
A federal judge in Philadelphia tossed out a complaint alleging McNeil Consumer Healthcare overcharged for OTC products that the firm recalled due to quality control issues at its Fort Washington, Pa., facility beginning in 2010.
Judge Dismisses Complaint Against McNeil Related To Recalled OTCs
A federal judge in Philadelphia tossed out a complaint alleging McNeil Consumer Healthcare overcharged for OTC products that the firm recalled due to quality control issues at its Fort Washington, Pa., facility beginning in 2010.